1.
|
Phase: Phase IV Type: Treatment Status: Active Age: 15 to 60 Sponsor: Other Protocol IDs: Hemato INCAN 01/2007, NCT00429065
|
|
2.
|
Phase: Phase IV Type: Treatment Status: Approved-not yet active Age: 21 and under Sponsor: Other Protocol IDs: TASMC-11-MB-442-CTIL, NCT01339988
|
|
3.
|
Phase: Phase III, Phase II Type: Supportive care, Treatment Status: Active Age: 0 to 18 Sponsor: Other Protocol IDs: CHU-0060, NCT01007617
|
|
4.
|
Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 1 to 55 Sponsor: Pharmaceutical / Industry Protocol IDs: GRASPALL2009-06, NCT01518517
|
|
5.
|
Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and under Sponsor: NCI Protocol IDs: COG-ANHL1131, ANHL1131, NCT01595048
|
|
6.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 3 to 20 Sponsor: NCI Protocol IDs: SCUSF-0402, HLMCC-0402, NCT00369564, ACCL 0731
|
|
7.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Tissue collection/Repository, Treatment Status: Active Age: 0 to 21 Sponsor: Other Protocol IDs: SJBC3, NCT01046825
|
|
8.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: not specified Sponsor: NCI, Other Protocol IDs: 2448.00, NCI-2010-02035, P01CA018029, NCT01231412
|
|
9.
|
Phase: Phase III Type: Treatment Status: Active Age: 6 months to 17 years Sponsor: Other Protocol IDs: Inter B-NHL Ritux 2010 Phase 3, 2010-019224-31, NCT01516580
|
|
10.
|
Phase: Phase III Type: Behavioral study, Treatment Status: Active Age: 1 to under 31 Sponsor: NCI Protocol IDs: NCI-2009-00307, CDR0000739567, U01CA98543, AALL0434, COG-AALL0434, NCT00408005
|
|
11.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: MSKCC-95024, NCI-V95-0685, NCT00002663
|
|
12.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 65 and under Sponsor: NCI, Other Protocol IDs: 1409.00, NCI-2010-00130, P01CA078902, FHCRC-1409.00, 4903, NCI-G00-1776, NCT00005803
|
|
13.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 4 to 21 Sponsor: NCI Protocol IDs: NCI-01-C-0125F, NCT00020592
|
|
14.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 70 and under Sponsor: Other Protocol IDs: 8713-HIMSUM, NCT00058825
|
|
15.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 12 to 60 Sponsor: Other Protocol IDs: CIK#2/2007, NMRC/1097/2006, NCT00460694
|
|
16.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 70 and under Sponsor: Other Protocol IDs: BCM-H-19386, BCM-FAB, H 19386, NCT00625144
|
|
17.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: Any age Sponsor: NCI, Other Protocol IDs: 2230.00, NCI-2010-00106, P01CA078902, FHCRC-2230.00, IR-6771, NCT00789776
|
|
18.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 30 and under Sponsor: Other Protocol IDs: AAAA5185, CHNY-01-501, NCT00802113
|
|
19.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 1 to 21 Sponsor: NCI Protocol IDs: COG-ADVL0912, ADVL0912, NCT00939770
|
|
20.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 1 to 74 Sponsor: NCI Protocol IDs: 080051, 08-C-0051, NCT00923910
|
|
21.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 1 to 21 Sponsor: Other Protocol IDs: T2008-002, NCT00981799
|
|
22.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 15 to 60 Sponsor: Other Protocol IDs: BHS-UCB2009, NCT01092026
|
|
23.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 6 montha to 70 Sponsor: Other Protocol IDs: J1055, NA_00039823, NCT01203722
|
|
24.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 8 to 65 Sponsor: Pharmaceutical / Industry Protocol IDs: GC P#01.01.020, NCT01221857
|
|
25.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 2 to 20 Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: 100220, IND 59,056, NCT01222780
|